Toxicity management of chemotherapy for breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women aged >= 18 years old; 2. Stage I - ? invasive breast cancer; 3. Complete clinical pathological data; 4. Patients receiving neoadjuvant or adjuvant chemotherapy; 5. We plan to accept chemotherapy regimens containing anthracyclines and/or taxanes, including one week regimens, intensive regimens, and three week regimens.
Exclusion criteria
Exclusion criteria: 1. Have a history of malignant tumors in the past; 2. Diseases previously treated with cytotoxic drugs (such as rheumatic and autoimmune diseases); 3. Any physical condition that hinders participation in the research process (such as inability to cooperate with examinations, etc.); 4. Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neutropenia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting;alopecia; | — |
Countries
China
Contacts
The First Affiliated Hospital of Jinzhou Medical University